CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 123 filers reported holding CONCERT PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $46,000 | -73.6% | 7,400 | -50.0% | 0.00% | -100.0% |
| Q2 2019 | $174,000 | +21.7% | 14,800 | +64.4% | 0.00% | 0.0% |
| Q1 2019 | $143,000 | +62.5% | 9,000 | +21.6% | 0.00% | 0.0% |
| Q4 2018 | $88,000 | -38.5% | 7,400 | -17.8% | 0.00% | 0.0% |
| Q3 2018 | $143,000 | -7.1% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $154,000 | -21.8% | 9,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $197,000 | +55.1% | 9,000 | -6.2% | 0.00% | -50.0% |
| Q1 2016 | $127,000 | -39.2% | 9,600 | -13.5% | 0.00% | 0.0% |
| Q4 2015 | $209,000 | +2.0% | 11,100 | +1.8% | 0.00% | -33.3% |
| Q3 2015 | $205,000 | +31.4% | 10,900 | +3.8% | 0.00% | +50.0% |
| Q2 2015 | $156,000 | +9.9% | 10,500 | +11.7% | 0.00% | 0.0% |
| Q1 2015 | $142,000 | – | 9,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 3,135,289 | $46,246,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 2,006,211 | $29,592,000 | 5.76% |
| Lyon Street Capital, LLC | 463,064 | $6,830,000 | 2.63% |
| SENZAR ASSET MANAGEMENT, LLC | 335,445 | $4,948,000 | 1.21% |
| INGALLS & SNYDER LLC | 1,209,062 | $17,834,000 | 0.93% |
| Senvest Management, LLC | 314,629 | $4,641,000 | 0.31% |
| KNOTT DAVID M | 45,000 | $664,000 | 0.28% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 262,569 | $3,873,000 | 0.15% |
| PRINCETON CAPITAL MANAGEMENT INC | 14,607 | $215,000 | 0.11% |
| Manchester Capital Management LLC | 19,984 | $295,000 | 0.05% |